Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs

Europe’s Next Act

European innovators helped pave the way for the world’s first COVID-19 vaccines. What’s coming next from Europe’s academic and biotech leaders?

  • What are the weathervane companies that point to where European innovation is headed?
  • What partnering deals are making the European highlight reel?
  • What innovations are investors finding and funding in Europe?
  • Can the U.K.’s split from the EU foster new opportunities for each side?

Join your colleagues for the 21st Bio€quity Europe as industry leaders debate these questions and identify where Europe will continue to provide global leadership in biopharma innovation.

Registration includes:

  • Three days of strategic panels focused on Europe's Next Act
  • 130+ Presentations from European and Asian biotechs handpicked by BioCentury
  • 1x1 virtual partnering using EBD's PartneringOne System
  • European biotech executive report from Insights Partner, McKinsey & Co.
  • Opportunities for digital networking
  • Access to BioCentury business intelligence on European biotech and BioCentury BCIQ database to help you prepare for 1x1 virtual meetings with Presenting Companies and other attendees

Faculty

Karen Bernstein, Ph.D.
Chairman
BioCentury Inc.
Kate Bingham
Managing Partner
SV Health Investors
Simone Fishburn, Ph.D.
Vice President and Editor in Chief
BioCentury Inc.
Carole Nuechterlein
Head, Roche Venture Fund
Roche
Antoine Papiernik
Chairman and Managing Partner
Sofinnova Partners
View More Faculty
right-arrow

Sponsors

More
right-arrow
Sponsorship Opportunities Available for Bio€quity Europe 2022Speak with a BioCentury representative today

Presenting Companies

More
right-arrow
Interested in becoming a Presenting Company for the next Bio€quity Europe in Milan?Apply now to be considered for the Bio€quity Europe Class of 2022

Testimonials

“Bio€quity Europe is a 'must go' for both VCs and CEOs of life science companies in Europe ... it is THE event where you can feel the pulse of the industry ...”

Antoine Papiernik
Chairman and Managing Partner
Sofinnova Partners

"Bio€quity is for me the most important investor conference for life science in Europe. If you want to know how the investor community ticks and want to meet the most important companies and rising future stars in Europe it´s the place to be." ​

Harald Poth, Ph.D.
Senior Investment Manager
LBBW Venture​

"If you are a VC or biotech CEO in Europe this is the conference to attend. Bio€quity is a great venue bringing the relevant players together. It’s not too big, not too small and it’s THE place to network." ​

Christina Takke, Ph.D.
Managing Partner
V-Bio Ventures​

Registration includes:

  • Two days of strategic panels focused on Hotbeds of Newco Formation In Europe
  • Presentations from European and Asian biotechs handpicked by BioCentury
  • 1x1 meetings using EBD's partneringONE® System – two days in-person (May 17-18), plus two days digital (May 23-24)
  • European biotech executive report from Insights Partner, McKinsey & Co.
  • Access to BioCentury business intelligence on European biotech and BioCentury's BCIQ database to help you prepare for 1x1 meetings
  • Peer-to-peer VIP networking

The Road to Bio€quity Europe 2022 - Complimentary Download
BioCentury CEO David Flores joined the Technology Forum Life Sciences Week (Oct. 1, 2021, Milan, Italy) to discuss the Italian life sciences ecosystem, and to provide a preview of the 22nd Bio€quity Europe conference, which will be held in Milan for the first time in May 2022.
The presentation is now available for download.

BEE 2022